[PRESENT STATE OF ANTINEOPLASTIC CHEMOTHERAPY FROM THE  PHARMACOLOGIC POINT OF VIEW].
D000166:Acridines; D000970:Antineoplastic Agents; D001152:Arsenicals; D001375:Azaguanine; D001377:Azaserine; D002066:Busulfan; D002455:Cell Division; D002700:Chloramines; D003078:Colchicine; D006801:Humans; D015122:Mercaptopurine; D010600:Pharmacology; D011687:Purines; D013852:Thiotepa; D014265:Triethylenemelamine
D000166:Acridines; D000970:Antineoplastic Agents; D001152:Arsenicals; D002700:Chloramines; D011687:Purines; D001377:Azaserine; D013852:Thiotepa; D015122:Mercaptopurine; D014265:Triethylenemelamine; D002066:Busulfan; D001375:Azaguanine; D003078:Colchicine; C030985:purine
ACRIDINES; ANTINEOPLASTIC AGENTS; ARSENICALS; AZAGUANINE; AZASERINE; BUSULFAN; CELL DIVISION; CHLORAMINES; COLCHICINE; MERCAPTOPURINE; PHARMACOLOGY; PURINES; THIO-TEPA; TRIETHYLENE MELAMINE
STATO ATTUALE DELLA CHEMIOTERAPIA ANTINEOPLASTICA DAL PUNTO DI VISTA FARMACOLOGICO.